Porous Chitosan Scaffolds with Embedded Hyaluronic Acid/Chitosan/Plasmid-DNA Nanoparticles Encoding TGF-β1 Induce DNA Controlled Release, Transfected Chondrocytes, and Promoted Cell Proliferation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lu, Huading ^a   Lv, Lulu ^a   Dai, Yuhu ^a   Wu, Gang ^b   Zhao, Huiqing ^a   Zhang, Fucheng ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; PLASMID DNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL ADHESION; CELL CULTURE; CELL LABELING; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; EMBEDDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SYNTHESIS; GENETIC TRANSFECTION; HISTOLOGY; IN VITRO STUDY; MATRIX ATTACHMENT REGION; MICROSPORE CULTURE; NONHUMAN; PARTICLE SIZE; PHENOTYPE; SUPERNATANT; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; TRANSGENE; ZETA POTENTIAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84880733412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069950     Document Type: Article

References (43)

1. Bachmann G, Basad E, Lommel D, Steinmeyer J, (2004) [MRI in the follow-up of matrix-supported autologous chondrocyte transplantation (MACI) and microfracture]. Radiologe 44: 773-782 doi:10.1007/s00117-004-1084-y. PMID: 15278206.
2. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, et al. (2008) Clinical transplantation of a tissue-engineered airway. Lancet 372: 2023-2030 doi:10.1016/S0140-6736(08)61598-6. PMID: 19022496.
3. Asnaghi MA, Jungebluth P, Raimondi MT, Dickinson SC, Rees LE, et al. (2009) A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial. Biomaterials 30: 5260-5269 doi:10.1016/j.biomaterials.2009.07.018. PMID: 19647867.
4. Chung C, Burdick JA, (2008) Engineering cartilage tissue. Adv Drug Deliv Rev 60: 243-262 doi:10.1016/j.addr.2007.08.027. PMID: 17976858.
5. Guo T, Zhao J, Chang J, Ding Z, Hong H, et al. (2006) Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. Biomaterials 27: 1095-1103 doi:10.1016/j.biomaterials.2005.08.015, PMID: 16143394.
6. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG, (2005) Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26: 7095-7103 doi:10.1016/j.biomaterials.2005.05.083doi:10.1016/j.biomaterials.2005.05.083. PMID: 16023196.
7. Guo CA, Liu XG, Huo JZ, Jiang C, Wen XJ, et al. (2007) Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-beta1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng 103: 547-556 doi:10.1263/jbb.103.547. PMID: 17630127.
8. Lee JE, Kim KE, Kwon IC, Ahn HJ, Lee SH, et al. (2004) Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 25: 4163-4173 doi:10.1016/j.biomaterials.2003.10.057. PMID: 15046906.
9. Diao H, Wang J, Shen C, Xia S, Guo T, et al. (2009) Improved cartilage regeneration utilizing mesenchymal stem cells in TGF-beta1 gene-activated scaffolds. Tissue Eng Part A 15: 2687-2698 doi:10.1089/ten.TEA.2008.0621. PMID: 19216641.
10. Peng L, Cheng X, Zhuo R, Lan J, Wang Y, et al. (2009) Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering. J Biomed Mater Res A 90: 564-576 doi: 10.1002/jbm.a.32117. PMID: 18563823.
11. Chen J, Chen H, Li P, Diao H, Zhu S, et al. (2011) Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials 32: 4793-4805 doi:10.1016/j.biomaterials.2011.03.041. PMID: 21489619.
12. Tan H, Chu CR, Payne KA, Marra KG, (2009) Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 30: 2499-2506 doi:10.1016/j.biomaterials.2008.12.080. PMID: 19167750.
13. Ueno H, Nakamura F, Murakami M, Okumura M, Kadosawa T, et al. (2001) Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages. Biomaterials 22: 2125-2130 doi:10.1016/S0142-9612(00)00401-4. PMID: 11432592.
14. Mao S, Sun W, Kissel T, (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62: 12-27 doi:10.1016/j.addr.2009.08.004. PMID: 19796660.
15. Zhao X, Yu SB, Wu FL, Mao ZB, Yu CL, (2006) Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles. J Control Release 112: 223-228 doi:10.1016/j.jconrel.2006.01.016. PMID: 16556468.
16. Zhang X, Yu C, Xushi, Zhang C, Tang T, et al. (2006) Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun 341: 202-208 doi:10.1016/j.bbrc.2005.12.171. PMID: 16413501.
17. Gao Y, Xu Z, Chen S, Gu W, Chen L, et al. (2008) Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. Int J Pharm 359: 241-246 doi:10.1016/j.ijpharm.2008.03.037. PMID: 18479851.
18. Zhao QQ, Chen JL, Lv TF, He CX, Tang GP, et al. (2009) N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex. Biol Pharm Bull 32: 706-710 doi:10.1248/bpb.32.706. PMID: 19336909.
19. Lu HD, Zhao HQ, Wang K, Lv LL, (2011) Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Int J Pharm 420: 358-365 doi:10.1016/j.ijpharm.2011.08.046. PMID: 21911044.
20. Yamane S, Iwasaki N, Majima T, Funakoshi T, Masuko T, et al. (2005) Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue engineering. Biomaterials 26: 611-619 doi:10.1016/j.biomaterials.2004.03.013. PMID: 15282139.
21. Duceppe N, Tabrizian M, (2009) Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Biomaterials 30: 2625-2631 doi:10.1016/j.biomaterials.2009.01.017. PMID: 19201022.
22. Elder SH, Nettles DL, Bumgardner JD (2004) Synthesis and characterization of chitosan scaffolds for cartilage-tissue engineering. Methods Mol Biol 238: 41-48. PMID: 14970437.
23. Pieper JS, Oosterhof A, Dijkstra PJ, Veerkamp JH, van Kuppevelt TH, (1999) Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20: 847-858 doi:10.1016/S0142-9612(98)00240-3. PMID: 10226711.
24. Shi DH, Cai DZ, Zhou CR, Rong LM, Wang K, et al. (2005) Development and potential of a biomimetic chitosan/type II collagen scaffold for cartilage tissue engineering. Chin Med J (Engl) 118: 1436-1443. PMID: 16157047.
25. Sezer AD, Akbuǧa J, (2009) Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): Formulation design and release characteristics. AAPS Pharm Sci Tech 10: 1193-1199 doi:10.1208/s12249-009-9324-0. PMID: 19859814.
26. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ, (1988) Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174: 168-176 doi:10.1016/0003-2697(88)90532-5. PMID: 2464289.
27. Kuo YC, Wang CC, (2011) Surface modification with peptide for enhancing chondrocyte adhesion and cartilage regeneration in porous scaffolds. Colloids Surf B Biointerfaces 84: 63-70 doi:10.1016/j.colsurfb.2010.12.021. PMID: 21227663.
28. Wang S, Baum BJ, Yamano S, Mankani MH, Sun D, et al. (2000) Adenoviral-mediated gene transfer to mouse salivary glands. J Dent Res 79: 701-708 doi:10.1177/00220345000790020201. PMID: 10728970.
29. Zhang Y, Cheng X, Wang J, Wang Y, Shi B, et al. (2006) Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering. Biochem Biophys Res Commun 344: 362-369 doi:10.1016/j.bbrc.2006.03.106. PMID: 16600180.
30. Rex TS, Tsui I, Hahn P, Maguire AM, Duan D, et al. (2004) Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress. Hum Gene Ther 15: 960-967 doi:10.1089/hum.2004.15.960. PMID: 15585111.
31. Shea LD, Smiley E, Bonadio J, Mooney DJ, (1999) DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17: 551-554 doi:10.1038/9853. PMID: 10385318.
32. Storrie H, Mooney DJ, (2006) Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev 58: 500-514 doi:10.1016/j.addr.2006.03.004. PMID: 16759734.
33. Lavertu M, Méthot S, Tran-Khanh N, Buschmann MD, (2006) High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27: 4815-4824 doi:10.1016/j.biomaterials.2006.04.029. PMID: 16725196.
34. Endo M, Kuroda S, Kondo H, Maruoka Y, Ohya K, et al. (2006) Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng 12: 489-497 doi:10.1089/ten.2006.12.489. PMID: 16579682.
35. Trentin D, Hubbell J, Hall H, (2005) Non-viral gene delivery for local and controlled DNA release. J Control Release 102: 263-275 doi:10.1016/j.jconrel.2004.09.029. PMID: 15653151.
36. Suh JK, Matthew HW, (2000) Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21: 2589-2598 doi:10.1016/S0142-9612(00)00126-5. PMID: 11071608.
37. Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG (2000) AID-JBM6>3.0.CO;2-S. PMID: 10880106.
38. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, et al. (1998) DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53: 183-193 doi:10.1016/S0168-3659(97)00252-6. PMID: 9741926.
39. de la Fuente M, Seijo B, Alonso MJ, (2008) Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci 49: 2016-2024 doi:10.1167/iovs.07-1077. PMID: 18436835.
40. Zheng F, Shi XW, Yang GF, Gong LL, Yuan HY, et al. (2007) Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sci 80: 388-396 doi:10.1016/j.lfs.2006.09.040. PMID: 17074366.
41. Bachrach G, Friedman M, Gilinski G, Steinberg D, (2006) Soluble sustained release gene delivery system. J Biomed Mater Res A 77: 811-814 doi:10.1002/jbm.a.30675. PMID: 16575909.
42. Ravi Kumar M, Hellermann G, Lockey RF, Mohapatra SS, (2004) Nanoparticle-mediated gene delivery: state of the art. Expert Opin Biol Ther 4: 1213-1224 doi:10.1517/14712598.4.8.1213. PMID: 15268657.
43. Elisseeff J, McIntosh W, Fu K, Blunk BT, Langer R, (2001) Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 19: 1098-1104 doi:10.1016/S0736-0266(01)00054-7. PMID: 11781011.